Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in nrx pharmaceuticals, inc, of class action lawsuit and upcoming deadline - nrxp; nrxpw

New york, new york--(newsfile corp. - march 14, 2022) - pomerantz llp announces that a class action lawsuit has been filed against nrx pharmaceuticals, inc. ("nrx" or the "company") (nasdaq: nrxp) (nasdaq: nrxpw) and certain of its officers. the class action, filed in the united states district court for the district of delaware, and docketed under 22-cv-00066, is on behalf of a class consisting of all persons and entities other than defendants that...
NRXP Ratings Summary
NRXP Quant Ranking